Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 65%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 50% · prior close shown (market closed)
4 signals not yet derived from pipeline evidence
Pipeline evidence · 33d ago
Reported figures for Royalty Pharma plc — research only, not investment advice.
Theme: margin
Updated
What happened recently for Royalty Pharma plc (RPRX) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$58.60
Market cap
$22.74B
Profitable
Yes
Revenue $2.38B
Net income
$770.95M
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
US equity research on AlphaOS
Investment Snapshot above is the primary AlphaOS analysis for Royalty Pharma plc — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Structured stock intelligence for companies connected to this research.
Follow Royalty Pharma plc through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.